Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3069630 | 1.00 | ACHE (0.40) | ACHECA1CA2CA12CA9 | |
| SCHEMBL11141844 | 0.97 | ACHE (0.39) | ACHECA1CA2CA12CA9 | |
| Ammonia Solution, Strong SCHEMBL7757548 | 0.97 | ACHE (0.39) | ACHECA1CA2CA12CA9 | |
| SCHEMBL11139652 | 0.95 | ACHE (0.35) | ACHECA1CA2CA12CA9 | |
| SCHEMBL10824031 | 0.93 | ACHE (0.41) | ACHECA1CA2CA12CA9 | |
| SCHEMBL3073284 | 0.84 | ACHE (0.40) | ACHECA1CA2CA12CA9 | |
| SCHEMBL3075632 | 0.80 | ACHE (0.38) | ACHECA1CA2CA12CA9 | |
| SCHEMBL3074564 | 0.78 | ACHE (0.36) | ACHECA1CA2CA12CA9 | |
| SCHEMBL17285155 | 0.78 | ACHE (0.43) | ACHECA1CA2CA12CA9 | |
| SCHEMBL3074383 | 0.77 | ACHE (0.39) | ACHECA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1265906-B1 | FLUORINATED LUBRICANT ADDITIVES | DU PONT (US) | 2005-06-22 | — | — | EP | disclosed |
| US-6764984-B2 | CONTAINING FLUORINATION DITHIOPHOSPHONATE SALT | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-07-20 | — | — | US | disclosed |
| US-20030139300-A1 | Fluorinated lubricant additives | BEATTY RICHARD P (US) | 2003-07-24 | — | — | US | disclosed |
| US-6541430-B1 | Wear and friction resistance | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-04-01 | — | — | US | disclosed |
| EP-1265906-A1 | FLUORINATED LUBRICANT ADDITIVES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001072759-A1 | FLUORINATED LUBRICANT ADDITIVES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139300-A1 | Fluorinated lubricant additives | DSG1, FLNA, DGKI | ACHE 1629/4885CA1 563/4885CA2 1321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.